Trials / Completed
CompletedNCT06561633
The Influence Factors of Bispectral Index Values Increment Caused by Sugammadex
The Influence Factors of Bispectral Index Values Increment Caused by Sugammadex Administration During Steady-state Anesthesia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 135 (actual)
- Sponsor
- Jun Zhang · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Sugammadex administration may increase the bispectral index (BIS) values during general anesthesia. The purpose of this study was to investigate the influence factors leading to increase in BIS value caused by sugammadex administration when continuous use of general anesthetics.
Detailed description
Sugammadex administration may increase the bispectral index (BIS) values during general anesthesia. The purpose of this study was to investigate the influence factors leading to increase in BIS value caused by sugammadex administration when continuous use of general anesthetics. Patients undergoing elective surgery were included in this study. After surgery was completed while the train-of-four ratio was zero, a steady-state intravenous anesthesia was maintained to keep a BIS value within the range of 40-60 for at least 5 minutes. Patients received sugammadex 2 mg.kg-1 after completed surgery. BIS values were recorded every minute and clinical signs of awaking was also noted.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sugammadex administration | After surgery was completed while the train-of-four ratio was zero, a steady-state intravenous anesthesia was maintained to keep a BIS value within the range of 40-60 for at least 5 minutes. Patients received sugammadex 2 mg.kg-1 after completed surgery. |
Timeline
- Start date
- 2024-08-20
- Primary completion
- 2024-09-13
- Completion
- 2024-09-14
- First posted
- 2024-08-20
- Last updated
- 2024-09-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06561633. Inclusion in this directory is not an endorsement.